B. de Vos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
B. de Vos has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
C.R. Leemans
Department of Otolaryngology/Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
2 shared publicationsE.F. Hensen
Department of Otolaryngology/Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
2 shared publicationsA.W.J. Hoksbergen
Division of Vascular Surgery, Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands
1 shared publicationG.J. Blom
Department of Radiotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
1 shared publicationJ.A. Rijken
Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands
1 shared publicationJ.P. Bayley
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 24 May 2019
- Published by Wiley in Clinical Otolaryngology
- Vol. 44 (5) , 836-841
Evolving management strategies in head and neck paragangliomas: A single‐centre experience with 147 patients over a 60‐year period
- 24 May 2019
- Published by Wiley in Clinical Otolaryngology
- Vol. 44 (5) , 836-841
Open AccessEvolving management strategies in head and neck paragangliomas: A single‐centre experience with 147 patients over a 60‐year period
- Open Access
- 2 January 2018
- Published by Wiley in Clinical Otolaryngology
- Vol. 43 (3) , 841-845
A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family‐based study
Objective: In the Netherlands, the majority of hereditary head and neck paragangliomas (HNPGL) are caused by germline variants in the succinate dehydrogenase genes (SDHD, SDHB, SDHAF2). Here, we evaluate a four‐generation family linked to a novel SDHB gene variant with the manifestation of a HNPGL.Design: A family‐based study.Setting: The VU University Medical Center (VUmc) Amsterdam, a tertiary clinic for Otolaryngology and Head and Neck Surgery.Participants and main outcome measures: The index patients presented with an embryonic rhabdomyosarcoma and a non‐Hodgkin lymphoma. Array‐based comparative genomic hybridisation (aCGH) analysis and multiplex ligation‐dependent probe amplification (MLPA) revealed a novel deletion of exon 1‐3 in the SDHB gene, suspected to predispose to paraganglioma (PGL)/pheochromocytoma (PHEO) syndrome type 4. Subsequently, genetic counselling and DNA testing were offered to all family members at risk. Individuals that tested positive for this novel SDHB gene variant were counselled and additional clinical evaluation was offered for the identification of HNPGL and/or PHEO.Results: The DNA of 18 family members was tested, resulting in the identification of 10 carriers of the exon 1‐3 deletion in the SDHB gene. One carrier was diagnosed with a carotid body PGL and serum catecholamine excess, which was surgically excised. Negative SDHB immunostaining of the carotid body tumour confirmed that it was caused by the SDHB variant. The remaining 9 carriers showed no evidence of PGL/PHEO.Conclusion: Deletion of exon 1‐3 in the SDHB gene is a novel germline variant associated with the formation of hereditary HNPGL.
- 2 January 2018
- Published by Wiley in Clinical Otolaryngology
- Vol. 43 (3) , 841-845
Open AccessA novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family‐based study
Objective: In the Netherlands, the majority of hereditary head and neck paragangliomas (HNPGL) are caused by germline variants in the succinate dehydrogenase genes (SDHD, SDHB, SDHAF2). Here, we evaluate a four‐generation family linked to a novel SDHB gene variant with the manifestation of a HNPGL.Design: A family‐based study.Setting: The VU University Medical Center (VUmc) Amsterdam, a tertiary clinic for Otolaryngology and Head and Neck Surgery.Participants and main outcome measures: The index patients presented with an embryonic rhabdomyosarcoma and a non‐Hodgkin lymphoma. Array‐based comparative genomic hybridisation (aCGH) analysis and multiplex ligation‐dependent probe amplification (MLPA) revealed a novel deletion of exon 1‐3 in the SDHB gene, suspected to predispose to paraganglioma (PGL)/pheochromocytoma (PHEO) syndrome type 4. Subsequently, genetic counselling and DNA testing were offered to all family members at risk. Individuals that tested positive for this novel SDHB gene variant were counselled and additional clinical evaluation was offered for the identification of HNPGL and/or PHEO.Results: The DNA of 18 family members was tested, resulting in the identification of 10 carriers of the exon 1‐3 deletion in the SDHB gene. One carrier was diagnosed with a carotid body PGL and serum catecholamine excess, which was surgically excised. Negative SDHB immunostaining of the carotid body tumour confirmed that it was caused by the SDHB variant. The remaining 9 carriers showed no evidence of PGL/PHEO.Conclusion: Deletion of exon 1‐3 in the SDHB gene is a novel germline variant associated with the formation of hereditary HNPGL.